Prevalence of human papillomavirus and HPV vaccination among cisgender bisexual women: Protocol for a systematic review and meta-analysis
4 affiliations
- 1Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
- 2School of Public Health, University of Washington, Seattle, Washington, United States of America.
- 3Department of Health Systems and Population Health, University of Washington, Seattle, Washington, United States of America.
- 4Department of Anthropology, University of Washington, Seattle, Washington, United States of America.
Abstract
Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and a primary cause of cervical cancer. Although cervical cancer is largely preventable through HPV vaccination, vaccine coverage remains suboptimal. Research on HPV prevalence and vaccination among cisgender bisexual women is limited and inconsistent. This may be partly due to variation in how bisexuality is defined. Bisexuality may be operationalized based on sexual identity (e.g., self-identification as bisexual) or sexual behavior (e.g., sexual contact with more than one sex or gender), and these differing definitions may capture distinct populations and yield divergent health findings. This paper proposes a protocol for a systematic review and meta-analysis to examine whether reported HPV prevalence and vaccination rates among cisgender bisexual women differ based on whether bisexuality is defined by identity or behavior. The protocol is registered in PROSPERO (CRD420251252015) and follows PRISMA-P guidelines. Random-effects meta-analyses will estimate pooled HPV prevalence and vaccination rates by definition type. Findings will clarify how operational definitions shape observed HPV-related outcomes and inform tailored cervical cancer prevention strategies for cisgender bisexual women.
Related
- Enablers and barriers to human papillomavirus vaccination implementation among key stakeholders in Ethiopia: A qualitative study
- Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria
- Prevalence of high-risk human papillomavirus genotypes and associated factors among HIV-infected women in a reproductive age group attending antiretroviral therapy in Nekemte town, Oromia, Ethiopia
- Effects of Feline Herpesvirus Type 1 Vaccination on Clinical Disease, Viral Shedding, and Post-Vaccination Reactions: A Systematic Review and Exploratory Meta-Analysis.
- Enrollment in participatory surveillance programs and influenza vaccination uptake: A systematic review protocol
BibTeX
@article{lawley2026prevalence,
title = {{Prevalence of human papillomavirus and HPV vaccination among cisgender bisexual women: Protocol for a systematic review and meta-analysis}},
author = {Kendall A Lawley and Karthikeya Kusuma and Stephanie A Farquhar and Steven M Goodreau and Rachel L Winer},
journal = {PLOS One},
year = {2026},
month = nov,
doi = {10.1371/journal.pone.0360427},
url = {https://doi.org/10.1371/journal.pone.0360427},
note = {CC BY},
}
RIS
TY - JOUR
TI - Prevalence of human papillomavirus and HPV vaccination among cisgender bisexual women: Protocol for a systematic review and meta-analysis
AU - Kendall A Lawley
AU - Karthikeya Kusuma
AU - Stephanie A Farquhar
AU - Steven M Goodreau
AU - Rachel L Winer
PY - 2026
DA - 2026/11/10
JO - PLOS One
DO - 10.1371/journal.pone.0360427
UR - https://doi.org/10.1371/journal.pone.0360427
AB - Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and a primary cause of cervical cancer. Although cervical cancer is largely preventable through HPV vaccination, vaccine coverage remains suboptimal. Research on HPV prevalence and vaccination among cisgender bisexual women is limited and inconsistent. This may be partly due to variation in how bisexuality is defined. Bisexuality may be operationalized based on sexual identity (e.g., self-identification as bisexual) or sexual behavior (e.g., sexual contact with more than one sex or gender), and these differing definitions may capture distinct populations and yield divergent health findings. This paper proposes a protocol for a systematic review and meta-analysis to examine whether reported HPV prevalence and vaccination rates among cisgender bisexual women differ based on whether bisexuality is defined by identity or behavior. The protocol is registered in PROSPERO (CRD420251252015) and follows PRISMA-P guidelines. Random-effects meta-analyses will estimate pooled HPV prevalence and vaccination rates by definition type. Findings will clarify how operational definitions shape observed HPV-related outcomes and inform tailored cervical cancer prevention strategies for cisgender bisexual women.
SN - 1932-6203
ER -